Results 161 to 170 of about 8,657 (242)

Targeting cuproptosis for treatment and prognostic assessment in endometrial cancer. [PDF]

Cancer Cell Int
Yu J, Shi H, Zhang J, Shan W, Xu Q, Shang H.   +5 more
europepmc   +1 more source

Polarized sorting of the copper transporter ATP7B in neurons mediated by recognition of a dileucine signal by AP-1

, 2014
Shweta Jain, Ginny G. Farı́as, Juan S. Bonifacino   +2 more
openalex   +1 more source

Molecular Characterization of Wilson's Disease in Liver Transplant Patients: A Five-Year Single-Center Experience in Iran. [PDF]

Diagnostics (Basel)
Beyzaei Z, Majed M, Dehghani SM, Imanieh MH, Khazaee A, Geramizadeh B, Weiskirchen R.   +6 more
europepmc   +1 more source

Mitochondrial dysfunction in Wilson disease: a systematic review and meta-analysis across human and animal models. [PDF]

Front Mol Biosci
Amin R, Medici V, Fausak ED, Sierra K, Li I, Gong J, Giulivi C.   +6 more
europepmc   +1 more source

Establishment and validation of a prognostic risk model based on ADME-related genes in breast cancer. [PDF]

Front Oncol
Yang Y, Yan L, Feng Y, Liu Y, Shi G, Hao J.   +5 more
europepmc   +1 more source

COMMD1 and PtdIns(4,5)P2 interaction maintain ATP7B copper transporter trafficking fidelity in HepG2 cells [PDF]

, 2019
Davis J. Stewart, Kristopher K. Short, Breanna N. Maniaci, Jason L. Burkhead   +3 more
openalex   +1 more source

ATP7B analysis of a Wilson disease family

Kanzo, 2013
Yasuaki Tatsumi, Yurie Miura, Ai Hattori, Hisao Hayashi, Kouichi Kato, Jun Ueyama, Shinya Wakusawa, Kazuhiko Hayashi, Yoshiaki Katano, Hidemi Goto   +9 more
openaire   +2 more sources

Analysis of the Correlation Between Cuproptosis and Instability of Atherosclerotic Plaques. [PDF]

Biomedicines
Muhetaer M, He T, Zhu H, Wu J, Wan J, Zhang T, Hu Y, Lu Z, Cai H.   +8 more
europepmc   +1 more source

Hemolytic anemia as first presentation of Wilson's disease with uncommon ATP7B mutation.

, 2015
Xingnong Ye, Liping Mao, Yinjun Lou, Hongyan Tong   +3 more
openalex   +1 more source

Metabolic stress-induced dysregulation of the Hippo signaling pathway inhibits the occurrence of hepatocarcinoma. [PDF]

Am J Cancer Res
Zhang S, Li L, Jin L, Li Z, Tao Q, Zhou F, Lu X, Zhang Q, Hu G, Huang L, Zhang L, Feng Q, Peng H, Yu Q.   +13 more
europepmc   +1 more source